A new scientific statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system. A new Scientific Statement ...

New research reveals previously unknown ways opioid receptors can function, opening the door to safer pain treatments.

Polyrizon Ltd., a biotech company focused on developing intranasal hydrogels, has started preclinical studies for an intranasal formulation of Naloxone, intended to treat opioid overdoses.

Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating with ...

Aili Langford receives funding from the Australian National Health and Medical Research Council through an Investigator Grant Fellowship. She sits on the Executive Committee of the Australian ...